Thus, it was recently demonstrated that the attenuation of the low-density lipoprotein receptor-related protein 6 (LRP6)-Wnt/β-catenin signaling pathway through microRNA-183 (miR-183) inhibits osteosarcoma cell proliferation and invasion (17). Here, LRP6 is linked to osteosarcoma.